カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のパーキンソン病治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Parkinsons Disease Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	■ 発行会社/調査会社：GlobalInfoResearch ■ 商品コード：GIR22NO19513 ■ 発行日：2022年11月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：106 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（注文後2-3日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のパーキンソン病治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

パーキンソン病治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のパーキンソン病治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

パーキンソン病治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のパーキンソン病治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Teva、Novartis AG、GSK、AbbVie、Merck、Boehringer Ingelheim、Impax Laboratories、Lundbeck、Sun Pharma、Wockhardt、UCB、Bausch Health、Acadia

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、パーキンソン病治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパーキンソン病治療薬メーカーの企業概要、2019年～2022年までのパーキンソン病治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパーキンソン病治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別パーキンソン病治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのパーキンソン病治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのパーキンソン病治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびパーキンソン病治療薬の産業チェーンを掲載しています。
・第13、14、15章では、パーキンソン病治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- パーキンソン病治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のパーキンソン病治療薬市場規模・予測
- 世界のパーキンソン病治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Teva、Novartis AG、GSK、AbbVie、Merck、Boehringer Ingelheim、Impax Laboratories、Lundbeck、Sun Pharma、Wockhardt、UCB、Bausch Health、Acadia
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：カルビドパ/レボドパ、ドーパミン受容体作動薬、MAO阻害薬
・用途別分析2017年-2028年：病院、診療所、その他
・パーキンソン病治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・パーキンソン病治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・パーキンソン病治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パーキンソン病治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・パーキンソン病治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Parkinsons Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Parkinsons Disease Drug market size is estimated to be worth US$ 5651 million in 2021 and is forecast to a readjusted size of USD 8374.4 million by 2028 with a CAGR of 5.8% during review period. Hospital accounting for % of the Parkinsons Disease Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Carbidopa/Levodopa segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Parkinsons Disease Drug include Teva, Novartis AG, GSK, AbbVie, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Parkinsons Disease Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market segment by Application can be divided into
Hospital
Clinics
Other
The key market players for global Parkinsons Disease Drug market are listed below:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parkinsons Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Parkinsons Disease Drug, with price, sales, revenue and global market share of Parkinsons Disease Drug from 2019 to 2022.
Chapter 3, the Parkinsons Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinsons Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Parkinsons Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinsons Disease Drug.
Chapter 13, 14, and 15, to describe Parkinsons Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Parkinsons Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinsons Disease Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinsons Disease Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Parkinsons Disease Drug Market Size & Forecast
1.4.1 Global Parkinsons Disease Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Parkinsons Disease Drug Sales in Volume (2017-2028)
1.4.3 Global Parkinsons Disease Drug Price (2017-2028)
1.5 Global Parkinsons Disease Drug Production Capacity Analysis
1.5.1 Global Parkinsons Disease Drug Total Production Capacity (2017-2028)
1.5.2 Global Parkinsons Disease Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinsons Disease Drug Market Drivers
1.6.2 Parkinsons Disease Drug Market Restraints
1.6.3 Parkinsons Disease Drug Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Parkinsons Disease Drug Product and Services
2.1.4 Teva Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Parkinsons Disease Drug Product and Services
2.2.4 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Parkinsons Disease Drug Product and Services
2.3.4 GSK Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Parkinsons Disease Drug Product and Services
2.4.4 AbbVie Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Parkinsons Disease Drug Product and Services
2.5.4 Merck Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Parkinsons Disease Drug Product and Services
2.6.4 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Impax Laboratories
2.7.1 Impax Laboratories Details
2.7.2 Impax Laboratories Major Business
2.7.3 Impax Laboratories Parkinsons Disease Drug Product and Services
2.7.4 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Lundbeck
2.8.1 Lundbeck Details
2.8.2 Lundbeck Major Business
2.8.3 Lundbeck Parkinsons Disease Drug Product and Services
2.8.4 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Parkinsons Disease Drug Product and Services
2.9.4 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Wockhardt
2.10.1 Wockhardt Details
2.10.2 Wockhardt Major Business
2.10.3 Wockhardt Parkinsons Disease Drug Product and Services
2.10.4 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 UCB
2.11.1 UCB Details
2.11.2 UCB Major Business
2.11.3 UCB Parkinsons Disease Drug Product and Services
2.11.4 UCB Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bausch Health
2.12.1 Bausch Health Details
2.12.2 Bausch Health Major Business
2.12.3 Bausch Health Parkinsons Disease Drug Product and Services
2.12.4 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Acadia
2.13.1 Acadia Details
2.13.2 Acadia Major Business
2.13.3 Acadia Parkinsons Disease Drug Product and Services
2.13.4 Acadia Parkinsons Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Parkinsons Disease Drug Breakdown Data by Manufacturer
3.1 Global Parkinsons Disease Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Parkinsons Disease Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Parkinsons Disease Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Parkinsons Disease Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Parkinsons Disease Drug Manufacturer Market Share in 2021
3.5 Global Parkinsons Disease Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Parkinsons Disease Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Parkinsons Disease Drug Market Size by Region
4.1.1 Global Parkinsons Disease Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Parkinsons Disease Drug Revenue by Region (2017-2028)
4.2 North America Parkinsons Disease Drug Revenue (2017-2028)
4.3 Europe Parkinsons Disease Drug Revenue (2017-2028)
4.4 Asia-Pacific Parkinsons Disease Drug Revenue (2017-2028)
4.5 South America Parkinsons Disease Drug Revenue (2017-2028)
4.6 Middle East and Africa Parkinsons Disease Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Parkinsons Disease Drug Sales in Volume by Type (2017-2028)
5.2 Global Parkinsons Disease Drug Revenue by Type (2017-2028)
5.3 Global Parkinsons Disease Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Parkinsons Disease Drug Sales in Volume by Application (2017-2028)
6.2 Global Parkinsons Disease Drug Revenue by Application (2017-2028)
6.3 Global Parkinsons Disease Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
7.2 North America Parkinsons Disease Drug Sales by Application (2017-2028)
7.3 North America Parkinsons Disease Drug Market Size by Country
7.3.1 North America Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
8.2 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
8.3 Europe Parkinsons Disease Drug Market Size by Country
8.3.1 Europe Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Parkinsons Disease Drug Market Size by Region
9.3.1 Asia-Pacific Parkinsons Disease Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Parkinsons Disease Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Parkinsons Disease Drug Sales by Type (2017-2028)
10.2 South America Parkinsons Disease Drug Sales by Application (2017-2028)
10.3 South America Parkinsons Disease Drug Market Size by Country
10.3.1 South America Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Parkinsons Disease Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Parkinsons Disease Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Parkinsons Disease Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Parkinsons Disease Drug Market Size by Country
11.3.1 Middle East & Africa Parkinsons Disease Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Parkinsons Disease Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Parkinsons Disease Drug
12.3 Parkinsons Disease Drug Production Process
12.4 Parkinsons Disease Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Parkinsons Disease Drug Typical Distributors
13.3 Parkinsons Disease Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Parkinsons Disease Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Parkinsons Disease Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Parkinsons Disease Drug Product and Services
Table 6. Teva Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Major Business
Table 9. Novartis AG Parkinsons Disease Drug Product and Services
Table 10. Novartis AG Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Parkinsons Disease Drug Product and Services
Table 14. GSK Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. AbbVie Basic Information, Manufacturing Base and Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Parkinsons Disease Drug Product and Services
Table 18. AbbVie Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Parkinsons Disease Drug Product and Services
Table 22. Merck Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim Major Business
Table 25. Boehringer Ingelheim Parkinsons Disease Drug Product and Services
Table 26. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Impax Laboratories Major Business
Table 29. Impax Laboratories Parkinsons Disease Drug Product and Services
Table 30. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 32. Lundbeck Major Business
Table 33. Lundbeck Parkinsons Disease Drug Product and Services
Table 34. Lundbeck Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Sun Pharma Major Business
Table 37. Sun Pharma Parkinsons Disease Drug Product and Services
Table 38. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 40. Wockhardt Major Business
Table 41. Wockhardt Parkinsons Disease Drug Product and Services
Table 42. Wockhardt Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. UCB Basic Information, Manufacturing Base and Competitors
Table 44. UCB Major Business
Table 45. UCB Parkinsons Disease Drug Product and Services
Table 46. UCB Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 48. Bausch Health Major Business
Table 49. Bausch Health Parkinsons Disease Drug Product and Services
Table 50. Bausch Health Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Acadia Basic Information, Manufacturing Base and Competitors
Table 52. Acadia Major Business
Table 53. Acadia Parkinsons Disease Drug Product and Services
Table 54. Acadia Parkinsons Disease Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Parkinsons Disease Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 56. Global Parkinsons Disease Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Parkinsons Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Parkinsons Disease Drug Production Capacity by Company, (K Doses): 2020 VS 2021
Table 59. Head Office and Parkinsons Disease Drug Production Site of Key Manufacturer
Table 60. Parkinsons Disease Drug New Entrant and Capacity Expansion Plans
Table 61. Parkinsons Disease Drug Mergers & Acquisitions in the Past Five Years
Table 62. Global Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 63. Global Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 64. Global Parkinsons Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Parkinsons Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 67. Global Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 68. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Parkinsons Disease Drug Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Parkinsons Disease Drug Price by Type (2017-2022) & (USD/Dose)
Table 71. Global Parkinsons Disease Drug Price by Type (2023-2028) & (USD/Dose)
Table 72. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 73. Global Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 74. Global Parkinsons Disease Drug Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Parkinsons Disease Drug Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Parkinsons Disease Drug Price by Application (2017-2022) & (USD/Dose)
Table 77. Global Parkinsons Disease Drug Price by Application (2023-2028) & (USD/Dose)
Table 78. North America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 79. North America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 80. North America Parkinsons Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Parkinsons Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 83. North America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 84. North America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 85. North America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 86. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 87. Europe Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 88. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Parkinsons Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 91. Europe Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 92. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 93. Europe Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 94. Asia-Pacific Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 95. Asia-Pacific Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 96. Asia-Pacific Parkinsons Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Parkinsons Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 99. Asia-Pacific Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 100. Asia-Pacific Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 101. Asia-Pacific Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 102. South America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 103. South America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 104. South America Parkinsons Disease Drug Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Parkinsons Disease Drug Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 107. South America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 108. South America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 109. South America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 110. Middle East & Africa Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 111. Middle East & Africa Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 112. Middle East & Africa Parkinsons Disease Drug Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Parkinsons Disease Drug Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 115. Middle East & Africa Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 116. Middle East & Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 117. Middle East & Africa Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 118. Parkinsons Disease Drug Raw Material
Table 119. Key Manufacturers of Parkinsons Disease Drug Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Parkinsons Disease Drug Typical Distributors
Table 123. Parkinsons Disease Drug Typical Customers
List of Figures
Figure 1. Parkinsons Disease Drug Picture
Figure 2. Global Parkinsons Disease Drug Revenue Market Share by Type in 2021
Figure 3. Carbidopa/Levodopa
Figure 4. Dopamine Receptor Agonists
Figure 5. MAO-Inhibitors
Figure 6. Global Parkinsons Disease Drug Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Other
Figure 10. Global Parkinsons Disease Drug Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global Parkinsons Disease Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Parkinsons Disease Drug Sales (2017-2028) & (K Doses)
Figure 13. Global Parkinsons Disease Drug Price (2017-2028) & (USD/Dose)
Figure 14. Global Parkinsons Disease Drug Production Capacity (2017-2028) & (K Doses)
Figure 15. Global Parkinsons Disease Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Parkinsons Disease Drug Market Drivers
Figure 17. Parkinsons Disease Drug Market Restraints
Figure 18. Parkinsons Disease Drug Market Trends
Figure 19. Global Parkinsons Disease Drug Sales Market Share by Manufacturer in 2021
Figure 20. Global Parkinsons Disease Drug Revenue Market Share by Manufacturer in 2021
Figure 21. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Parkinsons Disease Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Parkinsons Disease Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 25. Global Parkinsons Disease Drug Revenue Market Share by Region (2017-2028)
Figure 26. North America Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 27. Europe Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 29. South America Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Parkinsons Disease Drug Revenue (2017-2028) & (USD Million)
Figure 31. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Parkinsons Disease Drug Price by Type (2017-2028) & (USD/Dose)
Figure 34. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 35. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 36. Global Parkinsons Disease Drug Price by Application (2017-2028) & (USD/Dose)
Figure 37. North America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 39. North America Parkinsons Disease Drug Sales Market Share by Country (2017-2028)
Figure 40. North America Parkinsons Disease Drug Revenue Market Share by Country (2017-2028)
Figure 41. United States Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 45. Europe Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Parkinsons Disease Drug Sales Market Share by Country (2017-2028)
Figure 47. Europe Parkinsons Disease Drug Revenue Market Share by Country (2017-2028)
Figure 48. Germany Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Parkinsons Disease Drug Revenue Market Share by Region (2017-2028)
Figure 57. China Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 64. South America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 65. South America Parkinsons Disease Drug Sales Market Share by Country (2017-2028)
Figure 66. South America Parkinsons Disease Drug Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Parkinsons Disease Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Parkinsons Disease Drug in 2021
Figure 78. Manufacturing Process Analysis of Parkinsons Disease Drug
Figure 79. Parkinsons Disease Drug Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

世界のパーキンソン病治療薬市場2022年：市場規模予測（～2028年）

グローバル市場調査会社